Amanda Emmons

In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 111 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis and Structure−Activity Relationships of Long-acting β₂Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach

Panayiotis A. Procopiou, Victoria J. Barrett, Nicola Bevan et al. · Journal of Medicinal Chemistry · 2010 · 99 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors

Emmanuel H. Demont, Chun‐wa Chung, Rebecca C. Furze et al. · Journal of Medicinal Chemistry · 2015 · 79 citations · Full text

Pharmacy, Molecular Biology, Oncology +16

Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans

Andrew W. Harrell, Sarah Siederer, Jo Bal et al. · Drug Metabolism and Disposition · 2012 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings

Panayiotis A. Procopiou, Victoria J. Barrett, Nicola Bevan et al. · Bioorganic & Medicinal Chemistry · 2011 · 16 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13